← FDA Drug Approvals (Drugs@FDA)
ELTROMBOPAG OLAMINE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AIZANT · Approved 2026-04-28
Drug application
- FDA Application #
ANDA220660- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- ELTROMBOPAG OLAMINE
- Generic name
- Eltrombopag Olamine
- Active ingredients
- ELTROMBOPAG OLAMINE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- AIZANT
- First approval
- 2026-04-28
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown